Kulkarni, S.; Arunachala, S.; Chaya, S.K.; ShankaraSetty, R.V.; Karnik, M.; Bansal, N.; Ravindran, S.; Lokesh, K.S.; Mohan, M.; Kaleem Ullah, M.;
et al. The Assessment of Serum Fibronectin Levels as a Potential Biomarker for the Severity of Drug-Sensitive Pulmonary Tuberculosis: A Pilot Study. Diagnostics 2024, 14, 50.
https://doi.org/10.3390/diagnostics14010050
AMA Style
Kulkarni S, Arunachala S, Chaya SK, ShankaraSetty RV, Karnik M, Bansal N, Ravindran S, Lokesh KS, Mohan M, Kaleem Ullah M,
et al. The Assessment of Serum Fibronectin Levels as a Potential Biomarker for the Severity of Drug-Sensitive Pulmonary Tuberculosis: A Pilot Study. Diagnostics. 2024; 14(1):50.
https://doi.org/10.3390/diagnostics14010050
Chicago/Turabian Style
Kulkarni, Shreedhar, Sumalatha Arunachala, Sindaghatta Krishnarao Chaya, Rekha Vaddarahalli ShankaraSetty, Medha Karnik, Nidhi Bansal, Sukanya Ravindran, Komarla Sundararaja Lokesh, Mikash Mohan, Mohammed Kaleem Ullah,
and et al. 2024. "The Assessment of Serum Fibronectin Levels as a Potential Biomarker for the Severity of Drug-Sensitive Pulmonary Tuberculosis: A Pilot Study" Diagnostics 14, no. 1: 50.
https://doi.org/10.3390/diagnostics14010050
APA Style
Kulkarni, S., Arunachala, S., Chaya, S. K., ShankaraSetty, R. V., Karnik, M., Bansal, N., Ravindran, S., Lokesh, K. S., Mohan, M., Kaleem Ullah, M., Siddaiah, J. B., & Mahesh, P. A.
(2024). The Assessment of Serum Fibronectin Levels as a Potential Biomarker for the Severity of Drug-Sensitive Pulmonary Tuberculosis: A Pilot Study. Diagnostics, 14(1), 50.
https://doi.org/10.3390/diagnostics14010050
